Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • Invest with CPF/SRS
    • Singapore Stocks
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kalaris Therapeutics Inc.

2.59
-0.0727-2.73%
Volume:57.73K
Turnover:143.88K
Market Cap:48.39M
PE:-0.25
High:2.59
Open:2.58
Low:2.46
Close:2.66
52wk High:24.15
52wk Low:2.28
Shares:18.70M
Float Shares:3.90M
Volume Ratio:1.83
T/O Rate:1.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-10.3882
EPS(LYR):-10.4377
ROE:--
ROA:-681.04%
PB:0.76
PE(LYR):-0.25

Loading ...

OverviewCompanyNewsFilings

Kalaris Therapeutics Inc expected to post a loss of 52 cents a share - Earnings Preview

Reuters
·
Aug 05

Piper Sandler Initiates Kalaris Therapeutics at Neutral

MT Newswires Live
·
Jul 23

Kalaris Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 14

Kalaris Therapeutics Inc expected to post a loss of 77 cents a share - Earnings Preview

Reuters
·
May 10

William Blair Initiates Kalaris Therapeutics With Outperform Rating

MT Newswires Live
·
Apr 08

Kalaris Therapeutics appoints Leone Patterson to board of directors

TIPRANKS
·
Apr 04

BRIEF-Kalaris Expands Board Of Directors Appointing Leone Patterson As Chair Of Audit Committee

Reuters
·
Apr 04

Press Release: Kalaris Expands Board of Directors Appointing Leone Patterson as Chair of Audit Committee

Dow Jones
·
Apr 04

Press Release: Kalaris Announces Closing of Merger with AlloVir

Dow Jones
·
Mar 19

AlloVir Shareholders Approve Merger With Kalaris Therapeutics

MT Newswires Live
·
Mar 13

Analyst Rate

Buy
Buy
66.67%
Hold
33.33%
Sell
0.00%

Corporate Actions

Financial Report Announcement
May 14, 2025 Pre-Market
Financial Report Announcement
Mar 07, 2025 Pre-Market
Split&Reverse Split
Jan 16, 2025 23 for 1
Financial Report Announcement
Nov 12, 2024 Post Market
Financial Report Announcement
Aug 09, 2024 Pre-Market

Dividend History

no data

No relevant data is available

Valuation Analysis

-0.66
Current
-1.10
Sector Average
69.47%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-0.66
Maximum
-0.60
+1 STD
-0.49
Minimum
-2.44
-1 STD
-1.72
Average
-1.10

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.